Indication
Treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS) 2 months of age and older.
Medicine details
- Medicine name:
- maralixibat (Livmarli)
- SMC ID:
- SMC2757
- Pharmaceutical company
- Mirum Pharmaceuticals
- BNF chapter
- Nutrition and blood
- Submission type
- Resubmission
- Publication due date:
- 10 March 2025
- SMC meeting date:
- 04 February 2025
- Patient group submission deadline:
- TBC